| First Author | Chevessier F | Year | 2012 |
| Journal | Neurobiol Dis | Volume | 45 |
| Issue | 3 | Pages | 851-61 |
| PubMed ID | 22178625 | Mgi Jnum | J:182046 |
| Mgi Id | MGI:5314612 | Doi | 10.1016/j.nbd.2011.10.024 |
| Citation | Chevessier F, et al. (2012) A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR epsilonL221F mutation. Neurobiol Dis 45(3):851-61 |
| abstractText | We have generated a new mouse model for congenital myasthenic syndromes by inserting the missense mutation L221F into the epsilon subunit of the acetylcholine receptor by homologous recombination. This mutation has been identified in man to cause a mild form of slow-channel congenital myasthenic syndrome with variable penetrance. In our mouse model we observe as in human patients prolonged endplate currents. The summation of endplate potentials may account for a depolarization block at increasing stimulus frequencies, moderate reduced muscle strength and tetanic fade. Calcium and intracellular vesicle accumulation as well as junctional fold loss and organelle degeneration underlying a typical endplate myopathy, were identified. Moreover, a remodeling of neuromuscular junctions occurs in a muscle-dependent pattern expressing variable phenotypic effects. Altogether, this mouse model provides new insight into the pathophysiology of congenital myasthenia and serves as a new tool for deciphering signaling pathways induced by excitotoxicity at peripheral synapses. |
